Comprehensive Analysis of Hepatitis B Virus Promoter Region Mutations

Comprehensive Analysis of Hepatitis B Virus Promoter Region Mutations

Over 250 million people are infected chronically with hepatitis B virus (HBV), the leading cause of liver cancer worldwide. HBV persists, due, in part, to its compact, stable minichromosome, the covalently-closed, circular DNA (cccDNA), which resides in the hepatocytes’ nuclei. Current the...

Descripció completa

Dades bibliogràfiques
Autors principals:	Vanessa Meier-Stephenson, William T. R. Bremner, Chimone S. Dalton, Guido van Marle, Carla S. Coffin, Trushar R. Patel
Format:	Article
Idioma:	English
Publicat:	MDPI AG 2018-11-01
Col·lecció:	Viruses
Matèries:	Hepatitis B virus (HBV) cccDNA basal core promoter X promoter single nucleotide polymorphisms logo analyses genotype alignments
Accés en línia:	https://www.mdpi.com/1999-4915/10/11/603

Ítems similars

Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA
per: An-Qi Zhuang, et al.
Publicat: (2023-11-01)

Differences in sequences between HBV-relaxed circular DNA and covalently closed circular DNA
per: Magda Rybicka, et al.
Publicat: (2017-01-01)

Evaluation of the HBV liver reservoir with fine needle aspirates
per: Barbara Testoni, et al.
Publicat: (2023-10-01)

Recent Advances in the Development of Sulfamoyl-Based Hepatitis B Virus Nucleocapsid Assembly Modulators
per: Sandesha Nayak, et al.
Publicat: (2023-11-01)

When Hepatitis B Virus Meets Interferons
per: Guangyun Tan, et al.
Publicat: (2018-07-01)

Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA
per: Jihua Ren, et al.
Publicat: (2025-01-01)

Improved Specificity and Safety of Anti-Hepatitis B Virus TALENs Using Obligate Heterodimeric <i>Fok</i>I Nuclease Domains
per: Tiffany Smith, et al.
Publicat: (2021-07-01)

CRISPR/Cas9 for hepatitis B virus infection treatment
per: Bo Cai, et al.
Publicat: (2023-05-01)

Applications of CRISPR/Cas as a Toolbox for Hepatitis B Virus Detection and Therapeutics
per: Anuj Kumar, et al.
Publicat: (2024-10-01)

Immunoinformatics and Evaluation of Peptide Vaccines Derived from Global Hepatitis B Viral HBx and HBc Proteins Critical for Covalently Closed Circular DNA Integrity
per: Umar Saeed, et al.
Publicat: (2023-11-01)

Role of epigenetic modification in interferon treatment of hepatitis B virus infection
per: Zhijing Yang, et al.
Publicat: (2022-10-01)

Chronic Hepatitis B Genotype C Mouse Model with Persistent Covalently Closed Circular DNA
per: Deok-Hwa Seo, et al.
Publicat: (2024-12-01)

Hepatitis B virus genotypes and mutations in the basal core promoter and pre-core/core in chronically infected patients in southern Brazil: a cross-sectional study of HBV genotypes and mutations in chronic carriers
per: Flávia Miryan Martins Almeida de Mello, et al.
Publicat: (2014-12-01)

Crosstalk between Hepatitis B Virus and the 3D Genome Structure
per: João Diogo Dias, et al.
Publicat: (2022-02-01)

ZNF148 inhibits HBV replication by downregulating RXRα transcription
per: Xinyan Yao, et al.
Publicat: (2024-01-01)

Co-Transcriptional Regulation of HBV Replication: RNA Quality Also Matters
per: Guillaume Giraud, et al.
Publicat: (2024-04-01)

Post-translational Modification Control of HBV Biological Processes
per: Fan Yang
Publicat: (2018-11-01)

Dynamics of HBV cccDNA expression and transcription in different cell growth phase
per: Chong Chin-Liew, et al.
Publicat: (2011-12-01)

Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional CureSummary
per: Takashi Honda, et al.
Publicat: (2021-01-01)

Retrospective analysis of acute HBV infections occurred in 1978–79 and 1994–95 in North-East Italy: increasing prevalence of BCP/pre-core mutants in sub-genotype D3
per: Roberto Bruni, et al.
Publicat: (2020-01-01)

Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis
per: Gian Paolo Caviglia, et al.
Publicat: (2021-01-01)

Recent Advances in Hepatitis B Treatment
per: Georgia-Myrto Prifti, et al.
Publicat: (2021-05-01)

Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment
per: Xiaomei Wang, et al.
Publicat: (2021-01-01)

Augmented epigenetic repression of hepatitis B virus covalently closed circular DNA by interferon-α and small-interfering RNA synergy
per: Kongying Hu, et al.
Publicat: (2024-12-01)

Targeting HBV cccDNA Levels: Key to Achieving Complete Cure of Chronic Hepatitis B
per: Wei He, et al.
Publicat: (2024-12-01)

DNA Sensor ABCF1 Phase Separates With cccDNA to Inhibit Hepatitis B Virus Replication
per: Caiyue Ren, et al.
Publicat: (2024-12-01)

The potential of HBV cure: an overview of CRISPR-mediated HBV gene disruption
per: Zhi Q. Yao, et al.
Publicat: (2024-10-01)

Advances with RNAi-Based Therapy for Hepatitis B Virus Infection
per: Fiona van den Berg, et al.
Publicat: (2020-08-01)

Gene Editing Technologies to Target HBV cccDNA
per: Maria Guadalupe Martinez, et al.
Publicat: (2022-11-01)

Establishment of a fluorescent in situ hybridization assay for imaging hepatitis B virus nucleic acids in cell culture models
per: Xiaonan Zhang, et al.
Publicat: (2017-01-01)

Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis
per: François Villeret, et al.
Publicat: (2023-06-01)

Animal Models for the Study of Hepatitis B Virus Pathobiology and Immunity: Past, Present, and Future
per: Xiaonan Zhang, et al.
Publicat: (2021-07-01)

Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?
per: Sonia Alonso, et al.
Publicat: (2017-12-01)

Hepatitis B Viral Protein HBx: Roles in Viral Replication and Hepatocarcinogenesis
per: Dong Li, et al.
Publicat: (2024-08-01)

Lipid nanoparticle-encapsulated DOCK11-siRNA efficiently reduces hepatitis B virus cccDNA level in infected mice
per: Hikari Okada, et al.
Publicat: (2024-09-01)

A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation—and Beyond?
per: Sabrina Schreiner, et al.
Publicat: (2017-05-01)

cccDNA Surrogate MC-HBV–Based Screen Identifies Cohesin Complex as a Novel HBV Restriction FactorSummary
per: Zhuanchang Wu, et al.
Publicat: (2022-01-01)

Detection of HBV Covalently Closed Circular DNA
per: Xiaoling Li, et al.
Publicat: (2017-06-01)

Association between intrahepatic cccDNA and the severity of liver inflammation in chronic hepatitis B virus infection patients
per: Suxian Zhao, et al.
Publicat: (2025-01-01)

Cytosine base editing inhibits hepatitis B virus replication and reduces HBsAg expression in vitro and in vivo
per: Elena M. Smekalova, et al.
Publicat: (2024-03-01)